Monitoring Patients and Adverse Events GLP-1 compliance does not end after a prescription is issued
One AssuredPartners case study found GLP1 users saved about $560 per person per year in medical costs but against an average annual drug cost of $6,540, the nearterm ROI is negative for most employers
A study in a top medical journal found semaglutide helped with weight loss and heart health
This glucagon-like peptide-1 (GLP-1) medication imitates a hormone the body produces during food consumption
Results did not change when restricting the analysis to patients with NAFLD at baseline (15 patients in the liraglutide group, 16 in the sitagliptin group, and 15 in the placebo group) [76]
**Zdroje: Thondre PS, Lightowler H, Ahlstrom L, Gallagher A